Prof. Dan Peer scientific group developed genome editing system destroys cancer cells

Breakthrough treatment, with no side effects, may increase life expectancy in brain and ovarian cancer patients

23 November 2020

 

Prof. Dan Peer, former CBRC Chair, and his scientific team from the Department of Cell Research and Immunology at the Shmunis School of Biomedicine and Cancer Research, have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers, a significant step on the way to finding a cure for cancer.

 

The researchers developed a novel lipid nanoparticle-based delivery system that specifically targets cancer cells and destroys them by genetic manipulation. The system, called CRISPR-LNPs, carries a genetic messenger (messenger RNA), which encodes for the CRISPR enzyme Cas9 that acts as molecular scissors that cut the cells’ DNA.

 

Click here to read more >>

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>
Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
UI/UX Basch_Interactive